Delivery Order SPE2DB20D3303-SPE2DB24FA0NY

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Wegovy 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $1,188.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and an ultimate completion date of May 25, 2023. It is a delivery order contract, not associated with a specific set-aside requirement. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of Wegovy 1 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order has a ceiling value of $1,277.33 and an ultimate completion date of July 3, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Wegovy 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,108.48 and a delivery date of April 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award is for the delivery of Wegovy 0.5 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price of $3,291.24 and a completion date of June 12, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award is for the delivery of Wegovy 1 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $4,203.15 delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $11,393.45, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of October 21, 2024. The award was made on October 18, 2024, and there was no set-aside designation. AmerisourceBergen holds...
This federal contract award is for the delivery of Wegovy 0.25 mg/0.5 ml injection pens with a completion date of October 29, 2024. The contract, valued at $3,166.56, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp maintains a significant Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Wegovy 1 mg/0.5 ml pens (0.5 ml) to the government. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The award, valued at $10,745.75, is a Firm Fixed Price delivery order with an ultimate completion date of August 7, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds...
The federal contract award is for the delivery of Wegovy 1.7 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The $3,576.30 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical program, which covers a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of Wegovy 1 mg/0.5 ml pens, with a ceiling value of $1,818.16. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0NY
    Delivery Order

This federal contract award is for the delivery of Wegovy 2.4 mg/0.75 ml pens to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, valued at $1,062.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00 and running through December 2025, serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to the DLA and its supporting facilities worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/27/24, 9:31 AM